Executive Account Director, Business Development
Thermo Fisher Scientific- Full Time
- Junior (1 to 2 years)
Employment Type: Full-time Location Type: [Not Specified] Salary: [Not Specified]
Passionate about precision medicine and advancing the healthcare industry? Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
We are looking for a Key Account Director to join our rapidly growing Life Sciences team. This role will focus on creating and expanding our global client relationship with some of the world’s leading biopharmaceutical organizations. The Key Account Director will drive sales of Tempus RWD, AI, sequencing, and clinical trial solutions to major biopharma accounts with the goal of accelerating their research, clinical and/or commercial programs. Tempus services are used by more than 200 Biopharmas, including 18 of the top 20, to power their drug development programs. The Key Account Director will work cross-functionally with Tempus stakeholders to establish Tempus as the Precision Medicine Partner for their accounts.
[Not Specified]
Tempus is a technology company focused on precision medicine. Our proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.